APW
CNSY icon

Allied Private Wealth’s Cerenome CNSY Stock Holding History

Allied Private Wealth’s Portfolio CNSY Stock Details CNSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.89K Buy
+496
New +$2.71K ﹤0.01% 740

Other funds holding CNSY

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Allied Private Wealth's CNSY Position: Q2 2026 in Review

Allied Private Wealth opened a new position in Cerenome (CNSY) in Q2 2026: 496 shares worth $1.89K. The stake represents ﹤0.01% of the portfolio and ranks #740 among its holdings.

22 funds tracked by Wall St. Rank hold CNSY as of Q2 2026.

  • Allied Private Wealth held 496 shares of Cerenome worth $1.89K as of Q2 2026.
  • Cerenome was a new Allied Private Wealth position in Q2 2026.
  • Cerenome made up ﹤0.01% of Allied Private Wealth's portfolio in Q2 2026, its #740 holding.
  • 22 funds tracked by Wall St. Rank held Cerenome as of Q2 2026.

Based on Allied Private Wealth's 13F filing for Q2 2026, filed 9 Jul 2026.